BFM
IDYA icon

Boothbay Fund Management’s IDEAYA Biosciences IDYA Stock Holding History

Boothbay Fund Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,753
Closed -$925K – 2421
2026
Q1 		$925K Sell
27,753
-32,505
-54% -$1.09M 0.01% 990
2025
Q4 		$2.08M Sell
60,258
-14,508
-19% -$463K 0.03% 551
2025
Q3 		$2.03M Buy
74,766
+23,875
+47% +$577K 0.03% 567
2025
Q2 		$1.07M Buy
+50,891
New +$976K 0.02% 667
2023
Q4 		– Sell
-47,543
Closed -$1.28M – 1799
2023
Q3 		$1.28M Sell
47,543
-52,544
-52% -$1.33M 0.03% 657
2023
Q2 		$2.35M Buy
+100,087
New +$2.06M 0.05% 494

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Boothbay Fund Management's IDYA Position: Q2 2026 in Review

Boothbay Fund Management sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 27,753 shares — an estimated $925K sold.

Boothbay Fund Management first reported a position in IDYA in Q2 2023 and held it in 6 quarters. The position peaked at $2.35M in Q2 2023. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Boothbay Fund Management reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 27,753 IDEAYA Biosciences shares in Q2 2026, an estimated $925K.
  • Boothbay Fund Management first reported a position in IDEAYA Biosciences in Q2 2023 and held it in 6 quarters.
  • Boothbay Fund Management's IDEAYA Biosciences position peaked at $2.35M in Q2 2023.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.